Influence of Men's Attitudes toward Health and Health Insurance on Prostate Specific Antigen Screening for the Early Detection of Prostate Cancer

被引:0
|
作者
Stratton, Kelly L. [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Dept Urol, Oklahoma City, OK 73104 USA
关键词
Attitude to health; Early detection of cancer; Men's health; Prostate-specific antigen;
D O I
10.1097/01.UPJ.0000581960.51954.a1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The majority of guidelines currently recommend shared decision making for men 55 to 69 years old who are considering prostate specific antigen screening, and proceeding based on values and preferences. Qualitative studies have shown that negative attitudes toward physicians, health care and general health can influence decisions to pursue prostate specific antigen screening. We evaluated the impact of men's attitudes toward health and health insurance on prostate specific antigen screening. Methods: A retrospective secondary data analysis was conducted of men 55 to 69 years old without a history of prostate cancer using 2015 Medical Expenditure Panel Survey data. The relationships between 4 survey statements pertaining to attitudes toward health and health insurance and prostate specific antigen screening in the last 2 years were assessed using multiple logistic regression. Results: The analysis sample consisted of 1,771 men which equated to 20,498,788.2 once weighted, and of these men 63.1% underwent prostate specific antigen screening. Men who agreed 1) they did not need health insurance (OR 0.67, 95% CI 0.47-0.95), 2) health insurance was not worth the money it costs (OR 0.75, 95% CI 0.56-0.99), 3) they were more likely to take risks than the average person (OR 0.73, 95% CI 0.54-0.98) and 4) they could overcome illness without help from a medically trained person (OR 0.55, 95% CI 0.41-0.72) had significantly decreased adjusted odds of undergoing prostate specific antigen screening. Conclusions: Men with negative attitudes toward health and health insurance have significantly decreased odds of undergoing prostate specific antigen screening. With increased emphasis being placed on patient values, preferences and shared decision making, clinicians should assess for negative attitudes toward health and health insurance and intervene with these men to optimize the delivery of preventive care. Copyright © 2019 American Urological Association Education and Research, Inc.
引用
收藏
页码:363 / 363
页数:1
相关论文
共 50 条
  • [31] The role of prostate-specific antigen velocity in prostate cancer early detection
    Potter S.R.
    Carter H.B.
    Current Urology Reports, 2000, 1 (1) : 15 - 19
  • [32] Update on prostate-specific antigen testing for the early detection of prostate cancer
    Terrell, John D.
    Roehrborn, Claus G.
    Wians, Frank H., Jr.
    Karakiewicz, Pierre I.
    Shariat, Shahrokh F.
    LABMEDICINE, 2008, 39 (10): : 613 - 621
  • [33] What is the future of prostate-specific antigen for the early detection of prostate cancer?
    Getzenberg, Robert
    BJU INTERNATIONAL, 2008, 102 (02) : 157 - 158
  • [34] Prostate specific antigen density of the transition zone for early detection of prostate cancer
    Djavan, B
    Zlotta, AR
    Byttebier, G
    Shariat, S
    Omar, M
    Schulman, CC
    Marberger, M
    JOURNAL OF UROLOGY, 1998, 160 (02): : 411 - 418
  • [35] Can complexed prostate specific antigen enhance prostate cancer detection in Japanese men?
    Okihara, K
    Ukimura, O
    Nakamura, T
    Mizutani, Y
    Kawauchi, A
    Naya, Y
    Uchida, M
    Ogiwara, T
    Miki, T
    EUROPEAN UROLOGY, 2004, 46 (01) : 57 - 64
  • [36] Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter
    Horninger, W
    Cheli, CD
    Babaian, RJ
    Fritsche, HA
    Lepor, H
    Taneja, SS
    Childs, S
    Stamey, TA
    Sokoll, LJ
    Chan, DW
    Brawer, MK
    Partin, AW
    Bartsch, G
    UROLOGY, 2002, 60 (4A) : 31 - 35
  • [37] A retrospective study of prostate-specific antigen and international prostate symptoms scores from participants at a men's health screening initiative in Trinidad
    Khan, Raveed
    Hill, Ramona St.
    Awe, Olusegun
    Bhola, O'Reon
    Orumwense, Osayimwense
    Deosaran, Pavitra
    Seecharan, Priya
    Avula, Puneeth
    Mohammed, Rafiah
    Terapalli, Ashni
    Jardine, Rebecca M.
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (08) : 3214 - 3219
  • [38] The Influences of Health Insurance and Access to Information on Prostate Cancer Screening among Men in Dominican Republic
    Kangmennaang, Joseph
    Luginaah, Isaac
    JOURNAL OF CANCER EPIDEMIOLOGY, 2016, 2016
  • [39] Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate Cancer
    Ankerst, Donna Pauler
    Gelfond, Jonathan
    Goros, Martin
    Herrera, Jesus
    Strobl, Andreas
    Thompson, Ian M., Jr.
    Hernandez, Javier
    Leach, Robin J.
    JOURNAL OF UROLOGY, 2016, 196 (02): : 355 - 360
  • [40] Prostate-Specific Antigen Screening for Prostate Cancer in Older Men in the United States of America
    Black, Amanda
    Berg, Christine D.
    GERONTOLOGY, 2012, 58 (04) : 331 - 336